Hypocalcemia and hyperphosphatemia after phosphate enema use in a child
Related Experiment Video
Updated: Aug 15, 2026

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
Published on: March 14, 2017
M A Helikson1, W A Parham, J D Tobias
1Department of Surgery, School of Medicine, The University of Missouri, Columbia 65212, USA.
Insights
Hypertonic phosphate enemas can cause severe hyperphosphatemia and hypocalcemia, even in children. Prompt medical treatment is crucial for survival and preventing long-term effects.
Area of Science:
- Pediatric Nephrology
- Clinical Toxicology
- Gastroenterology
Background:
- Hypertonic phosphate enemas are commonly believed to be systemically inactive due to minimal absorption.
- This case challenges the assumption of safety, highlighting potential systemic toxicity.
Observation:
- A 3-year-old girl developed severe hyperphosphatemia and hypocalcemia following three adult-sized hypertonic phosphate enemas.
- Her serum phosphate level reached 74.7 mg/dL, a level exceeding previously reported cases.
Findings:
- The patient survived without sequelae due to early intervention and treatment.
- The study underscores that phosphate enemas can be significantly absorbed and cause systemic effects.
Implications:
- Physicians must recognize the potential adverse effects of hypertonic phosphate enemas, particularly in pediatric patients.
- Underlying conditions like altered gastrointestinal motility or renal insufficiency may increase susceptibility to phosphate toxicity.
- This case necessitates a re-evaluation of the safety profile and administration guidelines for phosphate enemas.
Abstract:
The authors present a 3-year-old girl in whom severe hyperphosphatemia and hypocalcemia developed after the administration of three adult-sized hypertonic phosphate enemas. The commonly held notion that these enemas are not absorbed and therefore are systemically inactive is incorrect. With early intervention and treatment, the child survived without sequelae despite a serum phosphate level (74.7 mg/dL) that is greater than those previously reported. The treatment of hyperphosphatemia is reviewed as well as underlying pathology such as altered gastrointestinal motility and renal insufficiency, which may predispose the patient to this problem. Physicians should be aware of the possible adverse effects that can be caused by hypertonic phosphate enemas.
Related Concept Videos
Introduction to Electrolytes
Role of Sodium
One...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Skeleton and Calcium Homeostasis
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily regulated...
Lower GI Series: Barium Enema
Procedure Details
The examination begins by inserting a lubricated rectal tube into the patient's rectum to administer a radiopaque barium solution. The barium flow is carefully...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention

